Bay Street News, August 2nd, 2024

Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability, and pharmacokinetics (PK) of quarterly and […]

KING CITY, Ontario, Aug. 02, 2024 (GLOBE NEWSWIRE) — Consolidated Financial Highlights (unaudited) (in thousands of dollars except per share […]

SINGAPORE and BURLINGTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) — Helport AI Limited (together with its operating subsidiaries, “Helport”) (Nasdaq: […]

Chengdu, China, Aug. 02, 2024 (GLOBE NEWSWIRE) — JIADE LIMITED (Nasdaq: JDZG) (the “Company”), a company that specializes in providing […]

SAN JOSE, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) — Infinera Corporation (NASDAQ: INFN) today released financial results for its second […]

TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) — Further to its news release dated July 10, 2024, Churchill Resources Inc. (“Churchill” […]

MALVERN, Pa., Aug. 02, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biotechnology company focused on discovering, developing, and […]

All amounts expressed in US dollars TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) – Given its […]

VANCOUVER, British Columbia, Aug. 02, 2024 (GLOBE NEWSWIRE) — Blender Bites Limited (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, […]

Not for distribution to U.S. news wire services or for dissemination in the United States VANCOUVER, British Columbia, Aug. 02, […]